1-Butyl-3-methyl-1H-imidazol-3-ium (S)-2-hydroxypropanoate

Catalog No. :
ACFASG834
CAS No. :
878132-20-8
Molecular Formula :
C11H20N2O3
Molecular Weight :
228.29

IUPAC Name:1-butyl-3-methyl-1H-imidazol-3-ium (S)-2-hydroxypropanoate

1-Butyl-3-methyl-1H-imidazol-3-ium (S)-2-hydroxypropanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
2g95%$88.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Butyl-3-methyl-1H-imidazol-3-ium (S)-2-hydroxypropanoate
IUPAC Name1-butyl-3-methyl-1H-imidazol-3-ium (S)-2-hydroxypropanoate
MDL No.MFCD03427627
Molecular FormulaC11H20N2O3
Molecular Weight228.29
SMILESC[N+]1=CN(CCCC)C=C1.O[C@@H](C)C([O-])=O
InChI KeyCYFFKUDZLZREEX-WNQIDUERSA-M
Synonym1-BUTYL-3-METHYLIMIDAZOLIUM (L)-LACTATE | 878132-20-8 | 1-butyl-3-methylimidazolium l-lactate | 1-butyl-3-methylimidazol-3-ium;(2S)-2-hydroxypropanoate | DTXSID301044521 | 1-Butyl-3-methylimidazolium(l)-lactate | CS-0456770 | E79246 | 1-Butyl-3-methyl-1H-imidazol-3-ium (
CAS No.878132-20-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFASG834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFASG834 route product structure diagram
    ACFASG834878132-20-8
Inquiry

2. ACFASG834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFASG834 route product structure diagram
    ACFASG834878132-20-8
Inquiry

Comments (0)